Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stuckey

Showing results (191-200 of 228) with videos related to

Pageof 23
Sort By:
Journal of Chemical Information and Modeling|May 7, 2016
CSAR 2014: A Benchmark Exercise Using Unpublished Data from PharmaHeather A Carlson, Richard D Smith, Kelly L Damm-Ganamet, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Nature Chemical Biology|February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivoAtsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
Journal of Medicinal Chemistry|November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor RegressionRenqi Xu, Haibin Zhou, Longchuan Bai, et al.
Journal of Chemical Information and Modeling|October 1, 2015
CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking ChallengeRichard D Smith, Kelly L Damm-Ganamet, James B Dunbar, et al.
Cancer Cell|November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In VivoLongchuan Bai, Haibin Zhou, Renqi Xu, et al.
Journal of Computer-Aided Molecular Design|October 4, 2016
D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictionsSymon Gathiaka, Shuai Liu, Michael Chiu, et al.
Cell Reports|February 9, 2016
KRAS Engages AGO2 to Enhance Cellular TransformationSunita Shankar, Sethuramasundaram Pitchiaya, Rohit Malik, et al.
Scientific Reports|January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activityEvelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Journal of Medicinal Chemistry|October 6, 2021
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor RegressionRohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Pageof 23

Showing results (191-200 of 228) with videos related to

Sort By:
Pageof 23
Journal of Chemical Information and Modeling|May 7, 2016
CSAR 2014: A Benchmark Exercise Using Unpublished Data from PharmaHeather A Carlson, Richard D Smith, Kelly L Damm-Ganamet, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Nature Chemical Biology|February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivoAtsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
Journal of Medicinal Chemistry|November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor RegressionRenqi Xu, Haibin Zhou, Longchuan Bai, et al.
Journal of Chemical Information and Modeling|October 1, 2015
CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking ChallengeRichard D Smith, Kelly L Damm-Ganamet, James B Dunbar, et al.
Cancer Cell|November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In VivoLongchuan Bai, Haibin Zhou, Renqi Xu, et al.
Journal of Computer-Aided Molecular Design|October 4, 2016
D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictionsSymon Gathiaka, Shuai Liu, Michael Chiu, et al.
Cell Reports|February 9, 2016
KRAS Engages AGO2 to Enhance Cellular TransformationSunita Shankar, Sethuramasundaram Pitchiaya, Rohit Malik, et al.
Scientific Reports|January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activityEvelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Journal of Medicinal Chemistry|October 6, 2021
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor RegressionRohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Pageof 23